Binding and internalization of the Helicobacter pylori vacuolating cytotoxin by epithelial cells

Many Helicobacter pylori strains produce a cytotoxin (VacA) that induces vacuolation in epithelial cells. In this study, binding and internalization of the cytotoxin by HeLa or AGS (human gastric adenocarcinoma) cells were characterized by indirect fluorescence microscopy. Cells incubated with the cytotoxin at 4 degrees C displayed a uniform fluorescent plasma membrane signal. Preincubation of the cytotoxin with either rabbit antiserum to approximately 90-kDa H. pylori VacA or sera from H. pylori-infected persons inhibited its binding to cells and blocked its capacity to induce cytoplasmic vacuolation. Recombinant VacA fragments (approximately 34 and approximately 58 kDa), corresponding to two proteolytic cleavage products of approximately 90-kDa VacA, each bound to the plasma membrane of HeLa cells. Antiserum reactive with the approximately 58-kDa VacA fragment inhibited the binding of native H. pylori cytotoxin to cells and inhibited cytotoxin activity, whereas antiserum to the approximately 34-kDa fragment had no effect. When incubated with cells at 37 degrees C for > or = 3 h, the H. pylori cytotoxin localized intracellularly in a perinuclear location but did not localize within cytotoxin-induced vacuoles. When cells with previously bound cytotoxin were incubated with anticytotoxin serum at 4 degrees C and then shifted to 37 degrees C, vacuolation was completely inhibited. Bound cytotoxin became inaccessible to the neutralizing effects of antiserum after 60 to 120 min of incubation with cells at 37 degrees C. These data suggest a model in which (i) VacA binds to cells primarily via amino acid sequences in its 58-kDa fragment, (ii) VacA internalization occurs slowly in a temperature-dependent process, and (iii) VacA interacts with an intracellular target.

[1]  M. Blaser,et al.  Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: role of VacA and CagA , 1996, Infection and immunity.

[2]  R. Rappuoli,et al.  Oligomeric and subunit structure of the Helicobacter pylori vacuolating cytotoxin , 1996, The Journal of cell biology.

[3]  T. Cover The vacuolating cytotoxin of Helicobacter pylori , 1996, Molecular microbiology.

[4]  M. Blaser,et al.  Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention. , 1996, Advances in internal medicine.

[5]  R. Rappuoli,et al.  Lipid interaction of the 37-kDa and 58-kDa fragments of the Helicobacter pylori cytotoxin. , 1995, European journal of biochemistry.

[6]  R. Rappuoli,et al.  Helicobacter pylori cytotoxin: importance of native conformation for induction of neutralizing antibodies , 1995, Infection and immunity.

[7]  M. Blaser,et al.  Mosaicism in Vacuolating Cytotoxin Alleles of Helicobacter pylori , 1995, The Journal of Biological Chemistry.

[8]  R. Rappuoli,et al.  Development of a mouse model of Helicobacter pylori infection that mimics human disease , 1995, Science.

[9]  S. Donta,et al.  Inhibition of Shiga-like toxins by brefeldin A. , 1995, The Journal of infectious diseases.

[10]  R. Rappuoli,et al.  Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  G. Schiavo,et al.  Bacterial protein toxins penetrate cells via a four‐step mechanism , 1994, FEBS letters.

[12]  R. Warnke,et al.  Helicobacter pylori infection and gastric lymphoma. , 1994, The New England journal of medicine.

[13]  M. Comanducci,et al.  Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease , 1994, The Journal of experimental medicine.

[14]  S. Normark,et al.  Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori , 1994, Infection and immunity.

[15]  M. Blaser,et al.  Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. , 1994, The Journal of biological chemistry.

[16]  R. Haas,et al.  Genetic analysis of the Helicobacter pylori vacuoiating cytotoxin: structural similarities with the IgA protease type of exported protein , 1994, Molecular microbiology.

[17]  Bisulfite or sulfite inhibits growth of Helicobacter pylori , 1994, Journal of clinical microbiology.

[18]  M. Blaser,et al.  Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo , 1993, Infection and immunity.

[19]  E. Papini,et al.  Cell vacuolization induced by Helicobacter pylori: inhibition by bafilomycins A1, B1, C1 and D. , 1993, FEMS microbiology letters.

[20]  M. Blaser,et al.  Effects of ATPase inhibitors on the response of HeLa cells to Helicobacter pylori vacuolating toxin , 1993, Infection and immunity.

[21]  E. Papini,et al.  Bafilomycin A1 inhibits Helicobacter pylori‐induced vacuolization of HeLa cells , 1993, Molecular microbiology.

[22]  N. Lam,et al.  Helicobacter pylori and peptic ulcer disease. , 1993, Clinical pharmacy.

[23]  C. Catrenich,et al.  Character and origin of vacuoles induced in mammalian cells by the cytotoxin of Helicobacter pylori. , 1992, Journal of medical microbiology.

[24]  I. Ohishi,et al.  Visualizations of binding and internalization of two nonlinked protein components of botulinum C2 toxin in tissue culture cells , 1992, Infection and immunity.

[25]  M. Blaser,et al.  Potentiation of Helicobacter pylori vacuolating toxin activity by nicotine and other weak bases. , 1992, The Journal of infectious diseases.

[26]  M. Blaser,et al.  Characterization of HeLa cell vacuoles induced by Helicobacter pylori broth culture supernatant. , 1992, Human pathology.

[27]  M. Blaser,et al.  Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori. , 1992, The Journal of clinical investigation.

[28]  M. Blaser,et al.  Purification and characterization of the vacuolating toxin from Helicobacter pylori. , 1992, The Journal of biological chemistry.

[29]  M. Blaser,et al.  Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. , 1991, The New England journal of medicine.

[30]  M. Blaser,et al.  Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin , 1991, Infection and immunity.

[31]  M. Blaser,et al.  Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity , 1990, Infection and immunity.

[32]  Grazia,et al.  Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only , 1989, Journal of clinical microbiology.

[33]  J. Brown,et al.  Direct cytotoxic action of Shiga toxin on human vascular endothelial cells , 1988, Infection and immunity.

[34]  D. Morgan,et al.  Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. , 1988, Journal of medical microbiology.

[35]  E. Hewlett,et al.  Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin , 1988, Infection and immunity.

[36]  P. Cassidy,et al.  Studies on the binding of staphylococcal 125I-labeled alpha-toxin to rabbit erythrocytes. , 1976, Biochemistry.